Literature DB >> 10510311

Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.

P J Pauwels1, A Gouble, T Wurch.   

Abstract

Constitutive activity of the recombinant human 5-hydroxytryptamine(1B) (5-HT(1B)) receptor (RC code 2.1.5HT.01.B) was investigated by mutagenesis of the BBXXB motif (in which B represents a basic residue and X a non-basic residue) located in the C-terminal portion of the third intracellular loop. In contrast with wild-type 5-HT(1B) receptors, three receptor mutants (Thr(313)-->Lys, Thr(313)-->Arg and Thr(313)-->Gln) increased their agonist-independent guanosine 5'-[gamma-[(35)S]thio]triphosphate binding response by 26-41%. This activity represented approx. 30% of the maximal response induced by 5-HT and could be reversed by the inverse agonists methiothepin and 3-(3-dimethylaminopropyl)-4-hydroxy-N-(4-pyridin-4-yl phenyl)-benzenamide (GR 55562). Enhanced agonist-independent and agonist-dependent 5-HT(1B) receptor activation was provided by co-expression of a pertussis toxin-resistant rat G(o)alpha Cys(351)-->Ile protein. The wild-type 5-HT(1B) receptor displayed a doubling in basal activity, whereas a spectrum of enhanced basal activities (313-571%) was observed with a series of diverse amino acid substitutions (isoleucine, glycine, asparagine, alanine, lysine, phenylalanine, glutamine and arginine) at the 5-HT(1B) receptor position 313 in the presence of pertussis toxin (100 ng/ml). Consequently, the constitutive 5-HT(1B) receptor activity can be modulated by the mutation of Thr(313), and displays a graded range between 11% and 59% of maximal 5-HT(1B) receptor activation by 5-HT. No clear pattern is apparent in the framework of traditionally cited amino acid characteristics (i.e. residue size, charge or hydrophobicity) to explain the observed constitutive activities. The various amino acid substitutions that yielded enhanced activity are unlikely to make similar intramolecular interactions within the 5-HT(1B) receptor. It is hypothesized that the positioning of the junction between the third intracellular loop and transmembrane domain VI is altered by mutation of Thr(313) in the BBXXB motif and thereby unmasks G(alpha)-protein interaction points.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510311      PMCID: PMC1220572     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

Review 1.  Reverse intrinsic activity of antagonists on G protein-coupled receptors.

Authors:  W Schütz; M Freissmuth
Journal:  Trends Pharmacol Sci       Date:  1992-10       Impact factor: 14.819

2.  Identification of a ligand-dependent switch within a muscarinic receptor.

Authors:  T A Spalding; E S Burstein; S C Henderson; K R Ducote; M R Brann
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

3.  A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty.

Authors:  A Shenker; L Laue; S Kosugi; J J Merendino; T Minegishi; G B Cutler
Journal:  Nature       Date:  1993-10-14       Impact factor: 49.962

4.  Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.

Authors:  C T Egan; K Herrick-Davis; M Teitler
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

Review 5.  Review: amino acid domains involved in constitutive activation of G-protein-coupled receptors.

Authors:  P J Pauwels; T Wurch
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

6.  Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding.

Authors:  T Wurch; F C Colpaert; P J Pauwels
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

Review 7.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins.

Authors:  R J Lefkowitz; S Cotecchia; P Samama; T Costa
Journal:  Trends Pharmacol Sci       Date:  1993-08       Impact factor: 14.819

8.  Constitutively active mutants of the alpha 2-adrenergic receptor.

Authors:  Q Ren; H Kurose; R J Lefkowitz; S Cotecchia
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

9.  Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands.

Authors:  E L Barker; R S Westphal; D Schmidt; E Sanders-Bush
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

10.  Inverse agonist activity of beta-adrenergic antagonists.

Authors:  P Chidiac; T E Hebert; M Valiquette; M Dennis; M Bouvier
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

View more
  9 in total

1.  Novel GαS-protein signaling associated with membrane-tethered amyloid precursor protein intracellular domain.

Authors:  Carole Deyts; Kulandaivelu S Vetrivel; Shibandri Das; Yumiko M Shepherd; Denis J Dupré; Gopal Thinakaran; Angèle T Parent
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

2.  A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.

Authors:  Wayne E Pratt; Kara A Clissold; Peagan Lin; Amanda E Cain; Alexa F Ciesinski; Thomas R Hopkins; Adeolu O Ilesanmi; Erin A Kelly; Zachary Pierce-Messick; Daniel S Powell; Ian A Rosner
Journal:  Brain Res       Date:  2016-07-16       Impact factor: 3.252

3.  Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the DRY motif and the third intracellular loop.

Authors:  Erika Peverelli; Andrea G Lania; Giovanna Mantovani; Paolo Beck-Peccoz; Anna Spada
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

4.  Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target.

Authors:  A Etxabe; M C Lara-Castillo; J M Cornet-Masana; A Banús-Mulet; M Nomdedeu; M A Torrente; M Pratcorona; M Díaz-Beyá; J Esteve; R M Risueño
Journal:  Leukemia       Date:  2017-02-14       Impact factor: 11.528

5.  Role of FQQI motif in the internalization, trafficking, and signaling of guanylyl-cyclase/natriuretic peptide receptor-A in cultured murine mesangial cells.

Authors:  Indra Mani; Renu Garg; Kailash N Pandey
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-16

6.  Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state.

Authors:  P J Pauwels; S Tardif; T Wurch; F C Colpaert
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

7.  Ligand-induced internalization of the type 1 cholecystokinin receptor independent of recognized signaling activity.

Authors:  Erin E Cawston; Kaleeckal G Harikumar; Laurence J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-02       Impact factor: 4.249

8.  Pharmacological characterization of 5-HT(1B) receptor-mediated inhibition of local excitatory synaptic transmission in the CA1 region of rat hippocampus.

Authors:  Boris Mlinar; Chiara Falsini; Renato Corradetti
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

9.  Crystal structure of the human 5-HT1B serotonin receptor bound to an inverse agonist.

Authors:  Wanchao Yin; X Edward Zhou; Dehua Yang; Parker W de Waal; Meitian Wang; Antao Dai; Xiaoqing Cai; Chia-Ying Huang; Ping Liu; Xiaoxi Wang; Yanting Yin; Bo Liu; Yu Zhou; Jiang Wang; Hong Liu; Martin Caffrey; Karsten Melcher; Yechun Xu; Ming-Wei Wang; H Eric Xu; Yi Jiang
Journal:  Cell Discov       Date:  2018-03-13       Impact factor: 10.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.